样式: 排序: IF: - GO 导出 标记为已读
-
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-19 Maria A Pabon, Muthiah Vaduganathan, Brian L. Claggett, Safia Chatur, Sara Siqueira, Pablo Marti-Castellote, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Carolyn S.P. Lam, Felipe Martinez, Sanjiv J. Shah, Akshay S. Desai, Pardeep S. Jhund, John J.V. McMurray, Scott D. Solomon, Orly Vardeny
-
Predicting survival after Impella implantation in patients with cardiogenic shock: The J-PVAD risk score Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-19 Toru Kondo, Tomo Yoshizumi, Ryota Morimoto, Takahiro Imaizumi, Shingo Kazama, Hiroaki Hiraiwa, Takahiro Okumura, Toyoaki Murohara, Masato Mutsuga
-
Reply to the letter regarding the article ‘Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-18 Nathanael Wood, Klaus K. Witte, T. Scott Bowen
We are grateful for the important and timely comments of Stöllberger and colleagues about our study on the effects of sodium–glucose cotransporter 2 inhibitors (SGLT2i) on skeletal muscle in people with heart failure and reduced ejection fraction (HFrEF).1 We agree entirely that further research is required to understand the effects of these agents on skeletal muscle structure and function, especially
-
Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy. Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-19 Emanuele Monda,Anna Murredda,Marta Rubino,Gaetano Diana,Giuseppe Palmiero,Federica Verrillo,Chiara Cirillo,Annapaola Cirillo,Adelaide Fusco,Giulia Frisso,Martina Caiazza,Giuseppe Limongelli
-
Letter regarding the article ‘Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-18 Claudia Stöllberger, Josef Finsterer, Birke Schneider
-
Myeloperoxidase: Reviving an old ally for immunomodulation in heart failure? Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-18 Gabriela M. Kuster, Birgit Assmus, Felix Mahfoud
-
Aficamten in non‐obstructive hypertrophic cardiomyopathy: Unlocking new horizons? Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-18 Maddalena Rossi, Enrico Fabris, Gianfranco Sinagra
-
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-16 Lars H. Lund, Stefan James, Adam D. DeVore, Kevin J. Anstrom, Marat Fudim, Keith D. Aaronson, Ulf Dahlström, Patrice Desvigne-Nickens, Jerome L. Fleg, Song Yang, Michael Fu, Camilla Hage, Claes Held, Patric Karlström, Magnus Nygren, Eric D. Peterson, Tymon Pol, Shelly Sapp, Johan Sundström, Ollie Östlund, Jonas Oldgren, Bertram Pitt
-
Timing of sodium–glucose cotransporter 2 inhibitor initiation and post‐discharge outcomes in acute heart failure with diabetes: A population‐based cohort study Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-13 Che‐Yuan Wu, Baiju R. Shah, Abhinav Sharma, Yiru Sheng, Peter P. Liu, Alexander Kopp, Refik Saskin, Jodi D. Edwards, Walter Swardfager
-
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-10 Lars H. Lund, Maria Generosa Crespo-Leiro, Cécile Laroche, Diana Zaliaduonyte, Aly M. Saad, Candida Fonseca, Jelena Čelutkienė, Marija Zdravkovic, Agata M. Bielecka-Dabrowa, Piergiuseppe Agostoni, Robert G. Xuereb, Kseniya V. Neronova, Malgorzata Lelonek, Yuksel Cavusoglu, Barnabas Gellen, Magdy Abdelhamid, Naima Hammoudi, Stefan D. Anker, Ovidiu Chioncel, Gerasimos Filippatos, Mitja Lainscak, Theresa
-
Efficacy and safety of angiotensin receptor–neprilysin inhibition in heart failure patients with end‐stage kidney disease on maintenance dialysis: A systematic review and meta‐analysis Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-10 Dung Viet Nguyen, Thanh Ngoc Le, Binh Quang Truong, Hoai Thi Thu Nguyen
-
The month in heart failure! September 2024 Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-10 Amr Abdin, Alberto Aimo, Julian Hoevelmann, Bernhard Haring
-
The persistent poor prognosis in cardiogenic shock: Insights from recent trials Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-10 Ameesh Isath, Mandeep R. Mehra
-
The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-10 Giovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, Vincenzo Castiglione, Marianna Adamo, Iacopo Fabiani, Victor Loghin, Carlo Mario Lombardi, Alessio Nicolai, Marco Metra, Michele Emdin, Alberto Aimo
-
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX‐AHF‐2 trial Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-06 Riccardo M. Inciardi, Laura Staal, Beth Davison, Carlo M. Lombardi, Douwe Postmus, Michael G. Felker, Gerasimos Filippatos, Barry Greenberg, Peter S. Pang, Piotr Ponikowski, Thomas Severin, Claudio Gimpelewicz, John Teerlink, Gad Cotter, Adriaan A. Voors, Marco Metra
-
Development and validation of a machine learning‐based approach to identify high‐risk diabetic cardiomyopathy phenotype Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-06 Matthew W. Segar, Muhammad Shariq Usman, Kershaw V. Patel, Muhammad Shahzeb Khan, Javed Butler, Lakshman Manjunath, Carolyn S.P. Lam, Subodh Verma, DuWayne Willett, David Kao, James L. Januzzi, Ambarish Pandey
-
Heart failure medical therapy in the last years of life: Prognosis and practicalities Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-03 Daniel J. Doherty, Amr Abdin, Kieran F. Docherty
-
Metabolic dysfunction and incidence of heart failure subtypes among Black individuals: The Jackson Heart Study Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-03 Arnaud D. Kaze, Alain G. Bertoni, Ervin R. Fox, Michael E. Hall, Robert J. Mentz, Justin B. Echouffo‐Tcheugui
-
The next era of gene‐specific clinical care in patients with dilated cardiomyopathy Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-02 Job A.J. Verdonschot, Stephane R.B. Heymans, Sophie Van Linthout
-
Reply to the letter regarding the article ‘Changes in 6‐min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-02 Peder L. Myhre, Kristian Berge, Stein Ørn
-
Letter regarding the article ‘Changes in 6‐min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-02 Emiliano Fiori, Damiano Magrì, Attilio Iacovoni
-
Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON‐HF trial Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-09-01 Henri Lu, Brian L. Claggett, Milton Packer, Marc A. Pfeffer, Carolyn S.P. Lam, Michael R. Zile, Akshay S. Desai, Pardeep Jhund, Martin Lefkowitz, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
-
Beta‐blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-31 Shingo Matsumoto, Alasdair D. Henderson, Li Shen, Toru Kondo, Mingming Yang, Ross T. Campbell, Inder S. Anand, Rudolf A. de Boer, Akshay S. Desai, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martinez, Milton Packer, Margaret M. Redfield, Jean L. Rouleau, Dirk J. Van Veldhuisen, Muthiah Vaduganathan, Faiez Zannad, Michael R. Zile, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray
-
Heart failure treatment in the last years of life: A nationwide study of 364 000 individuals Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-31 Johan Sundström, Stefan Gustafsson, Thomas Cars, Daniel Lindholm
-
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-30 Andrea Moreno-Arciniegas, Alberto García, Malte Kelm, Francesco D'Amore, María Gomes da Silva, Javier Sánchez-González, Pedro L. Sánchez, Teresa López-Fernández, Raul Córdoba, Riccardo Asteggiano, Vincent Camus, Jouke Smink, Antonio Ferreira, Marie J. Kersten, Natacha Bolaños, Noemi Escalera, Elsa Pacella, Sandra Gómez-Talavera, Antonio Quesada, Xavier Rosselló, Borja Ibanez
-
Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-30 Dirk J. van Veldhuisen, Michiel Rienstra, Arend Mosterd, A. Marco Alings, Antoinette D.J. van Asselt, Marcel L Bouvy, Jan G.P. Tijssen, Jeroen Schaap, Ernst E. van der Wall, Adriaan A. Voors, Eva M. Boorsma, Dirk J.A. Lok, Harry J.G.M. Crijns, Astrid Schut, Marlene A.T. Vijver, Geert H.D. Voordes, Agaath H. de Vos, Ester L. Maas-Soer, Nicoline W. Smit, Daan J. Touw, Michelle Samuel, Peter van der Meer
-
Burst steroid therapy for acute heart failure: The CORTAHF randomized, open‐label, pilot trial Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-30 Gad Cotter, Beth A. Davison, Yonathan Freund, Adriaan A. Voors, Christopher Edwards, Maria Novosadova, Koji Takagi, Hamlet Hayrapetyan, Andranik Mshetsyan, Drambyan Mayranush, Alain Cohen‐Solal, Jozine M. ter Maaten, Jan Biegus, Piotr Ponikowski, Gerasimos Filippatos, Ovidiu Chioncel, Malha Sadoune, Matteo Pagnesi, Tabassome Simon, Marco Metra, Douglas L. Mann, Alexandre Mebazaa
-
Inhibition of myeloperoxidase to treat left ventricular dysfunction in non‐ischaemic cardiomyopathy Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-30 Simon Geissen, Simon Braumann, Joana Adler, Felix Sebastian Nettersheim, Dennis Mehrkens, Alexander Hof, Henning Guthoff, Philipp von Stein, Sven Witkowski, Norbert Gerdes, Frederik Tellkamp, Marcus Krüger, Lea Isermann, Aleksandra Trifunovic, Alexander C. Bunck, Martin Mollenhauer, Holger Winkels, Matti Adam, Anna Klinke, Gregor Buch, Vincent ten Cate, Martin Hellmich, Malte Kelm, Volker Rudolph,
-
For improving the prognosis of patients with left ventricular assist device: Beyond the evaluation of caseload volume Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-29 Naoki Sato
-
Association between caseload volume and outcomes in left ventricular assist device implantations – a EUROMACS analysis Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-29 Maks Mihalj, David Reineke, Isabell A. Just, Johanna Mulzer, Nikolaos Cholevas, Christoph Hoermandinger, Kevin Veen, Markus M Luedi, Paul Philipp Heinisch, Evgenij Potapov, Jan F. Gummert, Paul Mohacsi, Christian Hagl, Gloria Faerber, Daniel Zimpfer, Theo M.M.H. de By, Bart Meyns, Finn Gustafsson, Lukas Hunziker, Matthias Siepe, Patrick Schober, Felix Schoenrath
-
Glycolysis in heart failure with preserved ejection fraction Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-28 Gary D. Lopaschuk, Qiuyu Sun, Ezra B. Ketema
-
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-28 Kalliopi Keramida, Dimitrios Farmakis, Amina Rakisheva, Carlo Gabriele Tocchetti, Pietro Ameri, Riccardo Asteggiano, Ana Barac, Jeroen Bax, Antoni Bayes‐Genis, Jutta Bergler Klein, Chiara Bucciarelli‐Ducci, Jelena Celutkiene, Andrew J.S. Coats, Alain Cohen Solal, Susan Dent, Gerasimos Filippatos, Arjun Ghosh, Joerg Hermann, Yvonne Koop, Daniel Lenihan, Teresa Lopez Fernandez, Alexander R. Lyon, Valentina
-
Dynamic evolution of tricuspid regurgitation during hospitalization in patients with acute decompensated heart failure Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-28 Eugenio Zocca, Daniele Cocianni, Davide Barbisan, Maria Perotto, Stefano Contessi, Jacopo Giulio Rizzi, Giulio Savonitto, Enrico Brollo, Elisa Soranzo, Antonio De Luca, Marco Merlo, Gianfranco Sinagra, Davide Stolfo
-
Association of ventricular–arterial coupling with biomarkers involved in heart failure pathophysiology – the STANISLAS cohort Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-27 Hannes Holm, Martin Magnusson, Amra Jujić, Jérémy Lagrange, Erwan Bozec, Zohra Lamiral, Emmanuel Bresso, Olivier Huttin, Guillaume Baudry, Luca Monzo, Patrick Rossignol, Faiez Zannad, Nicolas Girerd
-
Contemporary trends of atrial fibrillation management in heart failure patients: Do we practice what we preach? Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-27 Thomas Fink, Vanessa Sciacca, Paulus Kirchhof, Philipp Sommer
-
Heart failure risk assessment in patients with hypertrophic cardiomyopathy based on the H2FPEF score Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-27 Dorien Laenens, Thomas Zegkos, Vasileios Kamperidis, Raymond C.C. Wong, Tony Yi‐Wei Li, Ching‐Hui Sia, William K.F. Kong, Georgios Efthimiadis, Kian Keong Poh, Antonios Ziakas, Jeroen J. Bax, Nina Ajmone Marsan
-
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-22 Mingming Yang, Toru Kondo, Inder S. Anand, Rudolf A. de Boer, Ross T. Campbell, Lars Køber, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martinez, Eileen O'Meara, Milton Packer, Marc S. Sabatine, Jose F. Kerr Saraiva, Sanjiv J. Shah, Faiez Zannad, Michael R. Zile, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray
-
Decongestion in acute heart failure: Is it time to change diuretic‐centred paradigm? Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-22 Jan Biegus, Gad Cotter, Marco Metra, Piotr Ponikowski
-
Improving the rate of heart failure with improved ejection fraction Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-22 Evangelos Giannitsis, Norbert Frey, Pardeep S. Jhund
-
Differences in heart failure with preserved ejection fraction management between care providers: an international survey Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-22 Federica Guidetti, Clara Inés Saldarriaga Giraldo, Anastasia Shchendrygina, Keisuke Kida, David Niederseer, Carmen Basic, Peter P. Rainer, Marta Załęska‐Kocięcka, Elijah Ogola, Dania Mohty, Giuseppina Lanfranchi, Novi Yanti Sari, Hafsteinn Einarsson, Marzena Zurek, Frank Ruschitzka, Gianluigi Savarese, Nathan Mewton
-
Reply to 'Adrenomedullin as a marker of hypoxia, not hypoperfusion'. Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-19 Geert H D Voordes,Gad Cotter,Adriaan A Voors
-
Heart failure with preserved ejection fraction risk after aortic coarctation surgery: The hidden threat Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-19 Giancarlo Trimarchi, Giorgia Panichella, Alberto Aimo
-
Letter regarding the article ‘Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-19 Shiwei Xie, Lei Xu, Fan Zhang, Heng Xiao, Mingwei Luo
-
Reply to the letter regarding the article ‘Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-19 Rafael de la Espriella, Patricia Palau, Marco Guazzi, Julio Núñez
-
Empagliflozin and glucagon‐like peptide‐1 receptor agonists: The brothers for heart failure? Letter regarding the article ‘Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post‐hoc analysis from EMPULSE’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-19 Yue Hu, Zheng Li, Yingzi Zhang
-
Implementation of guideline‐directed medical therapy for heart failure: Progress achieved, work ahead! Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-19 Amr Abdin, Pardeep S. Jhund
-
-
Anthropometric measures and long‐term mortality in non‐ischaemic heart failure with reduced ejection fraction: Questioning the obesity paradox Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-19 Jawad H. Butt, Jens Jakob Thune, Jens C. Nielsen, Jens Haarbo, Lars Videbæk, Finn Gustafsson, Søren L. Kristensen, Niels E. Bruun, Hans Eiskjær, Axel Brandes, Christian Hassager, Jesper H. Svendsen, Dan E. Høfsten, Christian Torp‐Pedersen, Morten Schou, Steen Pehrson, Milton Packer, John J.V. McMurray, Lars Køber
-
Reverse cardiac remodelling: VICTORIA for inflammation and cardiac metabolism Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-16 Matthew M.Y. Lee, Alberto Aimo, Antoni Bayés‐Genís
-
Unravelling the complexity of heart failure with preserved ejection fraction and secondary mitral regurgitation Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-16 Philipp M. Doldi, Lukas Stolz, Jörg Hausleiter
-
Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure? Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-16 Guillaume Baudry, Marco Metra, Clément Delmas
Heart failure (HF) is a frequent and severe condition. It is estimated that one in four patients will die within a year following hospitalization for acute decompensation, with significant variations across age strata. A recent study reported that the 1-year mortality following hospitalization for HF was 9%, 14%, and 18% for patients under 55, between 55–64, and 65–74 years, respectively.1 Higher values
-
Reply to ‘Empagliflozin and glucagon‐like peptide‐1 receptor agonists: The brothers for heart failure?’ Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-15 João Pedro Ferreira, Adriaan A. Voors
-
Precision prediction of heart failure events in patients with dilated cardiomyopathy and mildly reduced ejection fraction using multi‐parametric cardiovascular magnetic resonance Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-15 Daniel J. Hammersley, Srinjay Mukhopadhyay, Xiuyu Chen, Richard E. Jones, Aaraby Ragavan, Saad Javed, Husein Rajabali, Emmanuel Androulakis, Lara Curran, Lukas Mach, Zohya Khalique, Resham Baruah, Kaushik Guha, John Gregson, Shihua Zhao, Antonio De Marvao, Upasana Tayal, Amrit S. Lota, James S. Ware, Dudley J. Pennell, Sanjay K. Prasad, Brian P. Halliday
-
Nurse‐led diuretic titration via a point‐of‐care urinary sodium sensor in patients with acute decompensated heart failure (EASY‐HF): A single‐centre, randomized, open‐label study Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-14 Evelyne Meekers, Pieter Martens, Jeroen Dauw, Henri Gruwez, Sebastiaan Dhont, Petra Nijst, Frederik H. Verbrugge, Koen Ameloot, David Verhaert, Matthias Dupont, Jorien Stassen, Marleen Opdenacker, Stefan Janssens, Wilfried Mullens
-
Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: 1-year outcomes of the multicentre, randomized ECMO-CS trial Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-08 Petr Ostadal, Richard Rokyta, Jiri Karasek, Andreas Kruger, Dagmar Vondrakova, Marek Janotka, Jan Naar, Jana Smalcova, Marketa Hubatova, Milan Hromadka, Stefan Volovar, Miroslava Seyfrydova, Ales Linhart, Jan Belohlavek
Among patients with cardiogenic shock, immediate initiation of extracorporeal membrane oxygenation (ECMO) did not demonstrate any benefit at 30 days. The present study evaluated 1-year clinical outcomes of the Extracorporeal Membrane Oxygenation in the therapy of Cardiogenic Shock (ECMO-CS) trial.
-
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-06 Alice Sacco, Andrea Montisci, Giovanni Tavecchia, Simone Frea, Davide Bernasconi, Costanza N.J. Colombo, Stephanie Bertolin, Giovanna Viola, Luca Villanova, Martina Briani, Lisa Patrini, Pier Paolo Bocchino, Carlotta Sorini Dini, Nicoletta D'Ettore, Maurizio Bertaina, Mario Iannaccone, Luciano Potena, Letizia Bertoldi, Serafina Valente, Rita Camporotondo, Marco Marini, Matteo Pagnesi, Marco Metra,
-
Landscape of glycolytic metabolites and their regulating proteins in myocardium from human heart failure with preserved ejection fraction Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-09 Navid Koleini, Mariam Meddeb, Liang Zhao, Mohammad Keykhaei, Seoyoung Kwon, Farnaz Farshidfar, Virginia S. Hahn, Erika L. Pearce, Kavita Sharma, David A. Kass
Heart failure (HF) with preserved ejection fraction (HFpEF) reflects half of all clinical HF yet has few therapies. Obesity and diabetes are now common comorbidities which have focused attention towards underlying myocardial metabolic defects. The profile of a major metabolic pathway, glycolytic intermediates and their regulating enzymes and ancillary pathways, remains unknown.
-
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT‐CHF (European) study with the ASIAN‐HF registry Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-09 Thong Huy Cao, Wan Ting Tay, Donald J.L. Jones, John G.F. Cleland, Jasper Tromp, Johanna Elisabeth Emmens, Tiew‐Hwa Katherine Teng, Chanchal Chandramouli, Oliver Charles Slingsby, Stefan D. Anker, Kenneth Dickstein, Gerasimos Filippatos, Chim C. Lang, Marco Metra, Piotr Ponikowski, Nilesh J. Samani, Dirk J. Van Veldhuisen, Faiez Zannad, Inder S. Anand, Carolyn S.P. Lam, Adriaan A. Voors, Leong L. Ng
-
Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-08 Karen Sliwa, Amina Rakisheva, Charle Viljoen, Tobias Pfeffer, Maggie Simpson, Alice M. Jackson, Mark C. Petrie, Peter van der Meer, Hasan Al Farhan, Silvana Jovanova, Amam Mbakwem, Gianfranco Sinagra, Emeline Van Craenenbroeck, Julian Hoevelmann, Mark R. Johnson, Richard Mindham, Ovidiu Chioncel, Kai G. Kahl, Giuseppe Rosano, Carsten Tschöpe, Alexandre Mebazaa, Petar Seferovic, Johann Bauersachs
-
The electrocardiogram in heart failure trials: Missing in action Eur. J. Heart Fail. (IF 16.9) Pub Date : 2024-08-06 Kelley P. Anderson